ALPHAMAB ONCOLOGY revenue breakdown overview

ALPHAMAB ONCOLOGY revenue for the last year amounted to 681.27 M HKD, the most of which — 693.99 M HKD — came from its highest performing source at the moment, Biologics of Oncology, the year earlier bringing 241.74 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought ALPHAMAB ONCOLOGY 693.99 M HKD, and the year before that — 241.74 M HKD.